ReviewMaterials today. Bio2026
Osteoimmunology uncovered: How macrophages and biomaterials revolutionize bone healing.
Review in Materials today. Bio, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- A 'three-axis synergy' immunotherapeutic strategy for malignant bone tumors based on natural bioactives and bioactive materials.Bioactive materials · 2026Review
- Surface Modification of Titanium with EGCG and Hexamethylenediamine Coating for BMP‑2 Grafting: An Investigation of Osteogenic Properties.ACS omega · 2026Article
- Bone‑origin repair in diabetic foot ulcers: Mechanisms of callus formation and endocrine effects in healing (Review).International journal of molecular medicine · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
With an increasingly aging society, bone defects and fractures have become significant threats to human health and quality of life. Currently, in situ bone repair represents a burgeoning niche within the realm of regenerative materials, achieving notable advancements in bone restoration. Numerous studies have successfully demonstrated the osteogenic potential of various biomaterials. Yet, discrepancies often emerge between in vitro and in vivo outcomes in bone healing, with the intricate in vivo microenvironment frequently failing to replicate the favorable osteogenic effects observed in vitro. The reasons behind these inconsistencies have seldom been explored in previous research. In recent years, advancements in bone microenvironment have revealed that osteoimmunology, of which macrophages are critical components, plays an essential regulatory role in bone regeneration. In this review, the role of macrophages in bone healing is explored and recent developments in biomaterials that promote bone regeneration by modulating osteo-microenvironment from the perspectives of physical and chemical signals are explored. Therefore, this article delves into the impact of macrophages on osteogenesis and provides insights of the mechanism behand it. Understanding how bone immune microenvironment regulate osteogenic outcomes under physical and chemical response can facilitate the design of bone repair materials that better adapt to the complex in vivo bone microenvironment, thereby enhancing their clinical translation.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.